FolFox6化疗方案治疗结直肠癌疗效观察临床医学.docVIP

FolFox6化疗方案治疗结直肠癌疗效观察临床医学 目录 TOC \o 1-9 \h \z \u 目录 1 正文 1 文1：FolFox6化疗方案治疗结直肠癌疗效观察临床医学 1 1 资料与方法 3 2 结果 4 3 结论 5 4 讨论 5 文2：两种方案治疗晚期非小细胞肺癌的疗效观察临床医学 8 1 临床资料 9 2 结果 11 3 讨论 12 参考文摘引言： 13 原创性声明（模板） 14 文章致谢（模板） 15 正文 FolFox6化疗方案治疗结直肠癌疗效观察临床医学 文1：FolFox6化疗方案治疗结直肠癌疗效观察临床医学 ［Abstract］ Objective To investigate and evaluate the effect of neoadjuvant chemotherapy on colorectal carcinoma and its postoperative complicatio and Screened 60 cases of colorectal carcinoma patients from October，2005 to October，2008 in the department of General Surgery，Union Hospital，Tongji Medical College，Huazhong Univeity of Science and them into two groups，one was treatment group（n=28），practiced the program of FolFox-6 preoperative chemotherapy fitly，then another surgery after had finished chemotherapy for 14 days practiced the program of FolFox-6 chemotherapy again，after 14 days rest and repeated the chemotherapy in 3 other was the control group（n=32） with no preoperative chemotherapy before the surgery and same postoperative chemotherapy after surgery with the treatment the standard of the efficacy of solid tumor in near future recommended by WHO to evaluate the efficacy of preoperative adjuvant chemotherapy in treatment the WHO grading standard of common toxicity of anti-cancer drug to evaluate the toxicity of preoperative adjuvant add up both groups of postoperative complicatio and ，both groups of patients were followed up to assess the prognosis of the Most of R of treatment group after preoperative adjuvant chemotherapy were above 60%; the toxicities of preoperative chemotherapy were short and light; there were no significant differences of postoperative complicatio after surgery in both groups of patients; local recurrence in the treatment group（%） was significantly lower than control group（%） and both groups of patients with long-term survival rates were % to %，there was no significant difference， Neoadjuvant chemotherapy for patients suffer